Cargando…
Targeting Mitochondrial Cell Death Pathway to Overcome Drug Resistance with a Newly Developed Iron Chelate
BACKGROUND: Multi drug resistance (MDR) or cross-resistance to multiple classes of chemotherapeutic agents is a major obstacle to successful application of chemotherapy and a basic problem in cancer biology. The multidrug resistance gene, MDR1, and its gene product P-glycoprotein (P-gp) are an impor...
Autores principales: | Ganguly, Avishek, Basu, Soumya, Chakraborty, Paramita, Chatterjee, Shilpak, Sarkar, Avijit, Chatterjee, Mitali, Choudhuri, Soumitra Kumar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889820/ https://www.ncbi.nlm.nih.gov/pubmed/20582168 http://dx.doi.org/10.1371/journal.pone.0011253 |
Ejemplares similares
-
A Novel Copper Chelate Modulates Tumor Associated Macrophages to Promote Anti-Tumor Response of T Cells
por: Chatterjee, Shilpak, et al.
Publicado: (2009) -
CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019) -
Dynamic Metabolism in Immune Response
por: Al-Hommrani, Mazen, et al.
Publicado: (2016) -
A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo
por: Mookerjee, Ananda, et al.
Publicado: (2006) -
The synthesis and properties of mitochondrial targeted iron chelators
por: Cilibrizzi, Agostino, et al.
Publicado: (2022)